A series of studies have shown that in a variety of tumours, such as colon cancer, non‐small cell lung cancer, and hepatocellular carcinoma, overexpressed LILRB2 was associated with a poor prognosis [36, 37, 38, 39, 40, 41]. This evidence concerns the gene LILRB2 and neoplasm.